Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: A randomized double-blind study in preterm infants

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 1 SUPPL., 2012, Pages

  Rayyan, Maissa ^a   Devlieger, Hugo ^a   Jochum, Frank ^b,c   Allegaert, Karel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Zentrum für Neonatologie und Pädiatrische Intensivmedizin   (Germany)

^c Department of Pediatrics ^*  (Germany)

Author keywords

Fatty acids; Fish oils; Liver function; Parenteral nutrition; Premature infant; Triglycerides

Indexed keywords

ALPHA TOCOPHEROL; BILIRUBIN; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPID EMULSION; MEDIUM CHAIN TRIACYLGLYCEROL; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; SMOFLIPID; SOYBEAN OIL; UNCLASSIFIED DRUG; FATTY ACID; TRIACYLGLYCEROL; VEGETABLE OIL;

ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMULSION; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; TREATMENT OUTCOME; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GROWTH, DEVELOPMENT AND AGING; LIVER; METABOLISM; METHODOLOGY; PROPORTIONAL HAZARDS MODEL;

DOUBLE-BLIND METHOD; EMULSIONS; ERYTHROCYTES; FATTY ACIDS; FEMALE; FISH OILS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LIVER; MALE; PARENTERAL NUTRITION; PHOSPHOLIPIDS; PLANT OILS; PROPORTIONAL HAZARDS MODELS; SOYBEAN OIL; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84860548422     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111424411     Document Type: Article

References (67)

1. Valentine CJ, Puthoff TD. Enhancing parenteral nutrition therapy for the neonate. Nutr Clin Pract. 2007;22:183-193.
2. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005;41(suppl 2):S1-S87.
3. Krohn K, Koletzko B. Parenteral lipid emulsions in paediatrics. Curr Opin Clin Nutr Metab Care. 2006;9:319-323.
4. Kerner JA Jr, Poole RL. The use of IV fat in neonates. Nutr Clin Pract. 2006;21:374-380.
5. Fleith M, Clandinin MT. Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr. 2005;45:205-229.
6. Innis SM. Fatty acids and early human development. Early Hum Dev. 2007;83:761-766.
7. Deckelbaum RJ. Intravenous lipid emulsions in pediatrics: time for a change? J Pediatr Gastroenterol Nutr. 2003;37:112-114.
8. Clandinin MT, Van Aerde JE, Merkel KL, et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr. 2005;146:461-468.
9. Koletzko B, Rodriguez-Palmero M, Demmelmair H, Fidler N, Jensen R, Sauerwald T. Physiological aspects of human milk lipids. Early Hum Dev. 2001;65(suppl):S3-S18.
10. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-181.
11. Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201-209.
12. Cetin I, Koletzko B. Long-chain omega-3 fatty acid supply in pregnancy and lactation. Curr Opin Clin Nutr Metab Care. 2008;11: 297-302.
13. Göbel Y, Koletzko B, Bohles HJ, et al. Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr. 2003;37:161-167.
14. Deshpande GC, Simmer K, Mori T, Croft K. Parenteral lipid emulsions based on olive oil compared with soybean oil in preterm (<28 weeks' gestation) neonates: a randomised controlled trial. J Pediatr Gastroenterol Nutr. 2009;49:619-625.
15. Sala-Vila A, Barbosa VM, Calder PC. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2007;10:165-174.
16. Lehner F, Demmelmair H, Roschinger W, et al. Metabolic effects of intravenous LCT or MCT/LCT lipid emulsions in preterm infants. J Lipid Res. 2006;47:404-411.
17. Koletzko B, Goulet O. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease. Curr Opin Clin Nutr Metab Care. 2010;13:321-326.
18. Devlieger H, De Pourcq L, Casneuf A, et al. Standard two-compartment formulation for total parenteral nutrition in the neonatal intensive care unit: a fluid tolerance based system. Clin Nutr. 1993;12:282-286.
19. Koumanov KS, Momchilova AB, Quinn PJ, Wolf C. Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity. Biochem J. 2002;363:45-51.
20. Rohmel J. Therapeutic equivalence investigations: statistical considerations. Stat Med. 1998;17:1703-1714.
21. Bauer P, Kieser M. A unifying approach for confidence intervals and testing of equivalence and difference. Biometrika. 1996;83: 934-937.
22. Colditz GA, Miller JN, Mosteller F. Measuring gain in the evaluation of a medical technology. Int J Technol Assess Health Care. 1988;4:637-642.
23. Ziegler EE, O'Donnell AM, Nelson SE, Fomon SJ. Body composition of the reference fetus. Growth. 1976;40:329-341.
24. Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010;51:514-521.
25. Rochow N, Moller S, Fusch G, Drogies T, Fusch C. Levels of lipids in preterm infants fed breast milk. Clin Nutr. 2010;29:94-99.
26. Bell EF. Transfusion thresholds for preterm infants: how low should we go? J Pediatr. 2006;149:287-289.
27. Bell EF. When to transfuse preterm babies. Arch Dis Child Fetal Neonatal Ed. 2008;93:F469-F473.
28. Fulford A, Scolapio JS, Aranda-Michel J. Parenteral nutrition-associated hepatotoxicity. Nutr Clin Pract. 2004;19:274-283.
29. Steinbach M, Clark RH, Kelleher AS, et al. Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant. J Perinatol. 2008;28:129-135.
30. Diamond IR, Sterescu A, Pencharz PB, Wales PW. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int. 2008;24:773-778.
31. Emerick KM, Whitington PF. Neonatal liver disease. Pediatr Ann. 2006;35:280-286.
32. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oilbased fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008;121:e678-e686.
33. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48:209-215.
34. Cowles RA, Ventura KA, Martinez M, et al. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg. 2010;45:84-87.
35. Antebi H, Mansoor O, Ferrier C, et al. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN J Parenter Enteral Nutr. 2004;28:142-148.
36. Piper SN, Schade I, Beschmann RB, Maleck WH, Boldt J, Rohm KD. Hepatocellular integrity after parenteral nutrition: comparison of a fish-oil-containing lipid emulsion with an olivesoybean oil-based lipid emulsion. Eur J Anaesthesiol. 2009;26: 1076-1082.
37. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010;34:485-495.
38. Van Gossum A, Shariff R, Lemoyne M, Kurian R, Jeejeebhoy K. Increased lipid peroxidation after lipid infusion as measured by breath pentane output. Am J Clin Nutr. 1988;48:1394-1399.
39. Pitkanen OM. Peroxidation of lipid emulsions: a hazard for the premature infant receiving parenteral nutrition? Free Radic Biol Med. 1992;13:239-245.
40. Weinberger B, Watorek K, Strauss R, Witz G, Hiatt M, Hegyi T. Association of lipid peroxidation with hepatocellular injury in preterm infants. Crit Care. 2002;6:521-525.
41. Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr. 2010;64:940-947.
42. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology. 1993;105:1806-1813.
43. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998;14:158-164.
44. Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology. 2006;43:9-19.
45. D'Ascenzo R, D'Egidio S, Angelini L, et al. Parenteral nutrition of preterm infants with a lipid emulsion containing 10% fish oil: effect on plasma lipids and long-chain polyunsaturated fatty acids. J Pediatr. 2011;159:33-38.
46. Clandinin MT, Chappell JE, Leong S. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev. 1980;4:121-129.
47. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids. 2006;75:329-349.
48. Lapillonne A, Jensen CL. Reevaluation of the DHA requirement for the premature infant. Prostaglandins Leukot Essent Fatty Acids. 2009;81:143-150.
49. Makrides M, Gibson RA, McPhee AJ, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA. 2009;301:175-182.
50. Boehm G, Borte M, Bohles HJ, Muller H, Kohn G, Moro G. Docosahexaenoic and arachidonic acid content of serum and red blood cell membrane phospholipids of preterm infants fed breast milk, standard formula or formula supplemented with n-3 and n-6 long-chain polyunsaturated fatty acids. Eur J Pediatr. 1996;155: 410-416.
51. Simopoulos AP. Metabolic effects of omega-3 fatty acids and essentiality. In: Spiller GA, ed. Handbook of Lipids in Human Nutrition. Boca Raton, FL: CRC Press; 1996:51-73.
52. Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008;1237:35-43.
53. Neuringer M. Infant vision and retinal function in studies of dietary long-chain polyunsaturated fatty acids: methods, results, and implications. Am J Clin Nutr. 2000;71:256S-267S.
54. Pontes-Arruda A. Using parenteral fish oil to modulate inflammatory response. JPEN J Parenter Enteral Nutr. 2010;34:344-345.
55. Koletzko B, Larque E, Demmelmair H. Placental transfer of longchain polyunsaturated fatty acids (LC-PUFA). J Perinat Med. 2007;35(suppl 1):S5-S11.
56. Carlson SE, Cooke RJ, Werkman SH, Tolley EA. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids. 1992;27:901-907.
57. Carlson SE, Werkman SH, Tolley EA. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr. 1996;63:687-697.
58. Simmer K, Schulzke SM, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev. 2008;(1):CD000375.
59. Koletzko B, Lien E, Agostoni C, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36:5-14.
60. Agostoni C, Buonocore G, Carnielli VP, et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010;50:85-91.
61. Carlson SE, Salem N Jr. Essentiality of ω 3 fatty acids in growth and development of infants. World Rev Nutr Diet. 1991;66:74-86.
62. Carlson SE, Werkman SH, Peeples JM. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA. 1993;90:1073-1077.
63. Carlson SE. Arachidonic acid status of human infants: influence of gestational age at birth and diets with very long chain n-3 and n-6 fatty acids. J Nutr. 1996;126:1092S-1098S.
64. Kurlak LO, Stephenson TJ. Plausible explanations for effects of long chain polyunsaturated fatty acids (LCPUFA) on neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:F148-F154.
65. Adolph M. Lipid emulsions in parenteral nutrition: state of the art and future perspectives. Clin Nutr. 2001;20(suppl 4):S11-S14.
66. Fürst P, Kuhn KS. Fish oil emulsions: what benefits can they bring? Clin Nutr. 2000;19:7-14.
67. Grimm H, Mertes N, Goeters C, et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr. 2006;45:55-60.